Gilmara Lima Nascimento
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gilmara Lima Nascimento has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alexander Itria
Universidade Federal de Goiás, Goiania, GO, Brasil
2 shared publicationsAna Lúcia Coutinho Domingues
Universidade Federal de Pernambuco, Recife, PE, Brasil
2 shared publicationsLuciane Nascimento Cruz
Instituto de Avaliação de Tecnologias em Saúde, Porto Alegre, RS, Brasil
2 shared publicationsMaria Regina Fernandes de Oliveira
Universidade de Brasília, Núcleo de Medicina Tropical, Brasília, DF, Brasil
2 shared publicationsRicardo Arraes de Alencar Ximenes
Universidade Federal de Pernambuco, Recife, PE, Brasil
2 shared publicationsHelio Milani Pegado
Universidade de Brasília, Núcleo de Medicina Tropical, Brasília, DF, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 114, e180347
The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni
Key words: schistosomiasis mansoni; cost of illness
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 114, e180347
Open AccessThe cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni
Key words: schistosomiasis mansoni; cost of illness
- 1 May 2018
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 112 (5) , 238-244
Quality of life and quality-adjusted life years of chronic schistosomiasis mansoni patients in Brazil in 2015
Measures of health-related quality of life (HRQoL) have been used to express the impact of neglected diseases and to generate indicators for health economic assessments. Schistosomiasis mansoni is a neglected disease with various clinical manifestations, including severe repercussions, caused by parasitic worms. Here we describe the quality of life of chronic schistosomiasis mansoni patients and estimate the quality-adjusted life years (QALYs) associated with chronic schistosomiasis mansoni in Brazil in 2015. A HRQoL study was carried out using the three-level European Quality of Life 5-Dimensions (EQ-5D-3L) questionnaire in 147 chronic schistosomiasis mansoni patients at an outpatient monitoring facility of an endemic state for schistosomiasis. Losses in HRQoL were observed in all five dimensions of the EQ-5D-3L. Patients >60 y and 40–49 y of age reported the highest frequencies of problems. The average utility index was 0.71, and the median index was significantly lower among female patients and patients with comorbidities (0.68; p<0.05) compared with the entire sample. Approximately 26.7 QALYs were estimated for the study population and 31.2 QALYs for the chronic schistosomiasis mansoni patients in Brazil. The advanced forms of schistosomiasis mansoni, even during treatment, contribute to important health losses in the population dealing with the disease.
- 1 May 2018
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 112 (5) , 238-244
Quality of life and quality-adjusted life years of chronic schistosomiasis mansoni patients in Brazil in 2015
Measures of health-related quality of life (HRQoL) have been used to express the impact of neglected diseases and to generate indicators for health economic assessments. Schistosomiasis mansoni is a neglected disease with various clinical manifestations, including severe repercussions, caused by parasitic worms. Here we describe the quality of life of chronic schistosomiasis mansoni patients and estimate the quality-adjusted life years (QALYs) associated with chronic schistosomiasis mansoni in Brazil in 2015. A HRQoL study was carried out using the three-level European Quality of Life 5-Dimensions (EQ-5D-3L) questionnaire in 147 chronic schistosomiasis mansoni patients at an outpatient monitoring facility of an endemic state for schistosomiasis. Losses in HRQoL were observed in all five dimensions of the EQ-5D-3L. Patients >60 y and 40–49 y of age reported the highest frequencies of problems. The average utility index was 0.71, and the median index was significantly lower among female patients and patients with comorbidities (0.68; p<0.05) compared with the entire sample. Approximately 26.7 QALYs were estimated for the study population and 31.2 QALYs for the chronic schistosomiasis mansoni patients in Brazil. The advanced forms of schistosomiasis mansoni, even during treatment, contribute to important health losses in the population dealing with the disease.